nhs tirzepatide England and NICE have approved the use of Tirzepatide, which you may also know as Mounjaro® or 'the weight loss drug', from primary care. You may well hear that is Mounjaro (Tirzepatide) Prescribing Update –

All patients were 45 years or older, with an initial BMI of 27 kg/m2 or greater and established CV disease (prior myocardial infarction, prior stroke, or peripheral arterial disease)

Temporary discontinuation In the Stark case series, both patients who discontinued semaglutide experienced complete resolution of allodynia symptoms

If you are taking Mounjaro alongside other glucose-lowering medications such as metformin, sulfonylureas, or insulin, your doctor may need to adjust these treatments to prevent either hyperglycaemia or hypoglycaemia after stopping tirzepatide

All of these benefits are achievable, but none are possible in isolation

Give you a psychological questionnaire (like the GAD-7)